$Supernus Pharmaceuticals, Inc.(SUPN)$ 8-K - Current report Filed: 2018-03-20 AccNo: 0001104659-18-018961 Size: 5 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantItem 3.02: Unregistere 网页链接